Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Heuser I, Maier W, Klosterkötter J, Falkai P, Schlösser R, Schmitt A, Riedel M, Klingberg S, Köpcke W, Ohmann C, Möller HJ.

Schizophr Res. 2014 Feb;152(2-3):478-86. doi: 10.1016/j.schres.2013.04.012. Epub 2013 May 1.

PMID:
23643327
2.

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia.

J Clin Psychiatry. 2007 Nov;68(11):1763-74.

PMID:
18052570
3.

Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, de Millas W, Maier W, Ruhrmann S, Falkai P, Sauer H, Schmitt A, Riedel M, Klingberg S, Möller HJ.

Schizophr Res. 2016 Jan;170(1):168-76. doi: 10.1016/j.schres.2015.10.024. Epub 2015 Nov 20.

PMID:
26607102
4.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
5.

Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.

Gaebel W, Möller HJ, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, Von Wilmsdorff M, Bottlender R, Klingberg S.

Eur Arch Psychiatry Clin Neurosci. 2004 Apr;254(2):129-40.

PMID:
15146342
6.

Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates.

Emsley R, Rabinowitz J, Medori R; Early Psychosis Global Working Group.

Schizophr Res. 2007 Jan;89(1-3):129-39. Epub 2006 Nov 7.

PMID:
17095194
7.

Remission after first-episode schizophrenia: results of a long-term follow-up.

Üçok A, Serbest S, Kandemir PE.

Psychiatry Res. 2011 Aug 30;189(1):33-7. doi: 10.1016/j.psychres.2010.11.013. Epub 2010 Dec 31.

PMID:
21196051
8.

Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.

Lieberman JA, Phillips M, Gu H, Stroup S, Zhang P, Kong L, Ji Z, Koch G, Hamer RM.

Neuropsychopharmacology. 2003 May;28(5):995-1003. Epub 2003 Mar 26.

9.

Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST).

Boter H, Peuskens J, Libiger J, Fleischhacker WW, Davidson M, Galderisi S, Kahn RS; EUFEST study group.

Schizophr Res. 2009 Dec;115(2-3):97-103. doi: 10.1016/j.schres.2009.09.019. Epub 2009 Oct 9.

PMID:
19819114
10.

Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks.

Kane JM, Crandall DT, Marcus RN, Eudicone J, Pikalov A 3rd, Carson WH, Swyzen W.

Schizophr Res. 2007 Sep;95(1-3):143-50. Epub 2007 Jul 17.

PMID:
17644313
11.

A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.

Stahl SM, Malla A, Newcomer JW, Potkin SG, Weiden PJ, Harvey PD, Loebel A, Watsky E, Siu CO, Romano S.

J Clin Psychopharmacol. 2010 Aug;30(4):425-30. doi: 10.1097/JCP.0b013e3181e69042. Erratum in: J Clin Psychopharmacol. 2010 Oct;30(5):652.

PMID:
20571437
12.

Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.

Chang WC, Ming Hui CL, Yan Wong GH, Wa Chan SK, Ming Lee EH, Hai Chen EY.

J Clin Psychiatry. 2013 Nov;74(11):e1046-53. doi: 10.4088/JCP.13m08355.

PMID:
24330905
13.

Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2 years: a 3-year open-label clinical study.

Emsley R, Oosthuizen PP, Koen L, Niehaus DJ, Martinez G.

J Clin Psychiatry. 2012 Apr;73(4):e541-7. doi: 10.4088/JCP.11m07138.

PMID:
22579160
14.

Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.

Novick D, Haro JM, Suarez D, Lambert M, Lépine JP, Naber D.

Psychopharmacology (Berl). 2007 May;191(4):1015-22. Epub 2007 Feb 20.

PMID:
17310386
15.

Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases.

Andreou C, Roesch-Ely D, Veckenstedt R, Bohn F, Aghotor J, Köther U, Pfueller U, Moritz S.

Psychiatry Res. 2013 Dec 30;210(3):729-34. doi: 10.1016/j.psychres.2013.08.019. Epub 2013 Aug 30.

PMID:
23998362
16.

Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia.

Lambert M, Naber D, Schacht A, Wagner T, Hundemer HP, Karow A, Huber CG, Suarez D, Haro JM, Novick D, Dittmann RW, Schimmelmann BG.

Acta Psychiatr Scand. 2008 Sep;118(3):220-9. doi: 10.1111/j.1600-0447.2008.01213.x.

PMID:
18699954
17.

Remission in first-episode psychosis: predictor variables and symptom improvement patterns.

Emsley R, Oosthuizen PP, Kidd M, Koen L, Niehaus DJ, Turner HJ.

J Clin Psychiatry. 2006 Nov;67(11):1707-12.

PMID:
17196049
18.

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van Hove I, Eerdekens M, Swyzen W, De Smedt G; Early Psychosis Global Working Group.

Am J Psychiatry. 2005 May;162(5):947-53.

PMID:
15863797
19.

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.

Riedel M, Mayr A, Seemüller F, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Schennach-Wolff R.

World J Biol Psychiatry. 2012 Jan;13(1):30-8. doi: 10.3109/15622975.2011.552633. Epub 2011 May 13.

PMID:
21568628

Supplemental Content

Support Center